Harbour Capital Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-9,054
Closed -$488K 208
2019
Q1
$488K Buy
9,054
+4,385
+94% +$271K 0.22% 125
2018
Q4
$306K Buy
+4,669
New +$349K 0.15% 154
2017
Q3
Sell
-5,700
Closed -$459K 258
2017
Q2
$459K Sell
5,700
-2,167
-28% -$171K 0.23% 135
2017
Q1
$618K Sell
7,867
-62
-0.8% -$4.95K 0.28% 105
2016
Q4
$626K Sell
7,929
-1,782
-18% -$144K 0.45% 82
2016
Q3
$864K Buy
9,711
+235
+2% +$22.2K 0.54% 60
2016
Q2
$907K Hold
9,476
0.51% 61
2016
Q1
$983K Buy
9,476
+1,120
+13% +$109K 0.56% 55
2015
Q4
$817K Buy
8,356
+629
+8% +$61.6K 0.44% 76
2015
Q3
$746K Buy
7,727
+1,800
+30% +$189K 0.53% 71
2015
Q2
$622K Buy
+5,927
New +$606K 0.39% 93

Other funds holding CVS

Harbour Capital Advisors's CVS Position: Q2 2019 in Review

Harbour Capital Advisors sold out of CVS Health (CVS) in Q2 2019, closing a stake of 9,054 shares — an estimated $488K sold.

Harbour Capital Advisors first reported a position in CVS in Q2 2015 and held it in 11 quarters. The position peaked at $983K in Q1 2016. 1,654 funds tracked by Wall St. Rank hold CVS as of Q2 2019.

  • Harbour Capital Advisors reported no remaining CVS Health position as of Q2 2019 after selling out during the quarter.
  • Harbour Capital Advisors sold 9,054 CVS Health shares in Q2 2019, an estimated $488K.
  • Harbour Capital Advisors first reported a position in CVS Health in Q2 2015 and held it in 11 quarters.
  • Harbour Capital Advisors's CVS Health position peaked at $983K in Q1 2016.
  • 1,654 funds tracked by Wall St. Rank held CVS Health as of Q2 2019.

Based on Harbour Capital Advisors's 13F filing for Q2 2019, filed 10 Jul 2019.